Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $27.2200 (-2.09%) ($27.1700 - $28.1300) on Thu. Jul. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.4% (three month average) | RSI | 43 | Latest Price | $27.2200(-2.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.8% a day on average for past five trading days. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(47%) IWC(45%) ARKG(42%) | Factors Impacting HALO price | HALO will decline at least -1.2% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) TLT(-2%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.2% (StdDev 2.4%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
Resistance Level | $27.68 | 5 Day Moving Average | $28.16(-3.34%) | 10 Day Moving Average | $28.16(-3.34%) | 20 Day Moving Average | $27.68(-1.66%) | To recent high | -6.3% | To recent low | 23.2% | Market Cap | $3.72b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |